{"product_id":"cedars-sinai-advances-in-nuclear-cardiology-cardiac-ct-and-cardiac-mri-38th-annual-case-review-with-the-experts-2026","title":"Cedars Sinai Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI 38th Annual Case Review with the Experts 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: cardiologists and radiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eSpecialties – Cardiology, Imaging, Nuclear Medicine, Radiology\u003c\/p\u003e\n\u003cp\u003eProfessions – Nurse, Nurse (Advanced Practice NP CRNA CNM CNS), Physician, Physician Assistant, Radiologic Technologist, Researcher (non-physician), Researcher (physician), Technician\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eObjectives\u003c\/p\u003e\n\u003cp\u003eIdentify up to date evidence regarding the information provided by tests, the appropriate use of testing an how the tests affect outcomes an costs in coronary and noncoronary heart and aortic disease\u003c\/p\u003e\n\u003cp\u003eRecognize the implications of 2019 ESC CTA ACCAHA chest pain guidelines on the use of noninvasive testing\u003c\/p\u003e\n\u003cp\u003eImplement the latest acquisition processing protocols, instrumentation and software for multiple imaging modalities\u003c\/p\u003e\n\u003cp\u003eExplain how new approaches to functional assessmentsuch as coronary flow reserve, noninvasive fractional flow reserve, and plaque measurementsenhance the information obtained from testing.\u003c\/p\u003e\n\u003cp\u003eImprove image interpretation and recognition of image artifacts\u003c\/p\u003e\n\u003cp\u003eRecognize strategies tor educe patient radiation and contrast exposure while conduct high quality studies\u003c\/p\u003e\n\u003cp\u003eApply optimal protocols for pharmacologic stress testing\u003c\/p\u003e\n\u003cp\u003eCreate optimal reports that integrate test findings and provide guidance for patient management\u003c\/p\u003e\n\u003cp\u003eIdentify the latest information regarding how test findings should be used to guide patient management decision\u003c\/p\u003e\n\u003cp\u003eUse criteria and evidence based strategies to reduce inappropriate testing\u003c\/p\u003e\n\u003cp\u003eIdentify knowledge gaps regarding blueprints for the CBNC and CBCCT Boards\u003c\/p\u003e\n\u003ch3\u003eTopics :\u003c\/h3\u003e\n\u003cp\u003eAI in Cardiac CTA- Quantification of Coronary Plaque- Prediction of Risk-Prediction, and Ischemia\u003c\/p\u003e\n\u003cp\u003eAmyloid Quantitation- Decreasing Subjectivity in PYP Interpretation\u003c\/p\u003e\n\u003cp\u003eAmyloid Specific PET Tracers\u003c\/p\u003e\n\u003cp\u003eBeyond Perfusion with MPI- AI Analysis of CAC, Chamber Volumes, Epicardial Fat, Body Composition and Beyond\u003c\/p\u003e\n\u003cp\u003eBeyond the Images- The Essential Role of Excercise and Functional Assessment in Cardiac Testing\u003c\/p\u003e\n\u003cp\u003eCardiac MRI and PET in Microvascular Disease\u003c\/p\u003e\n\u003cp\u003eCardiac MRI in Sarcoidosis and Other Inflammatory Cardiomyopathies\u003c\/p\u003e\n\u003cp\u003eCase-Based Interpretation of Flurpiridaz MPI\u003c\/p\u003e\n\u003cp\u003eCentral Role of Cardiac CT in Structural Heart Disease\u003c\/p\u003e\n\u003cp\u003eChanging the Outlook in Cardiac Amyloidosis- Current and Novel Therapies\u003c\/p\u003e\n\u003cp\u003eChoosing Between Flurpiridaz and Rubidium\u003c\/p\u003e\n\u003cp\u003eClass IA Guideline Recommendation for Chest Pain- What Evidence Brought Coronary CTA Here\u003c\/p\u003e\n\u003cp\u003eClinical Value of Myocardial Blood Flow Measurement\u003c\/p\u003e\n\u003cp\u003eCombining Anatomy and Physiology with SPECT and PET. Crucial Role of CAC Scanning in Patients\u003c\/p\u003e\n\u003cp\u003eCoronary Artery Calcium (CAC) Scanning- Central Role in Preventive Cardiology\u003c\/p\u003e\n\u003cp\u003eCoronary CT in Mitral Valve and Afib- Watchman and TMVR\u003c\/p\u003e\n\u003cp\u003eCoronary CTA and FFRct for the Interventionalist- Use in Planning and Guiding PCI\u003c\/p\u003e\n\u003cp\u003eCoronary CTA in Asymptomatic Patients\u003c\/p\u003e\n\u003cp\u003eCoronary CTA in Evaluation of Patients with Known CAD (Stents, CABG)\u003c\/p\u003e\n\u003cp\u003eCoronary CTA in Evaluation of Suspected CAD in Daily Practice\u003c\/p\u003e\n\u003cp\u003eCoronary CTA- Special Consideration for Women\u003c\/p\u003e\n\u003cp\u003eDebate- Coronary CTA Will Replace Stress Testing\u003c\/p\u003e\n\u003cp\u003eEvolving Trends in CAD- Shifting Risk Factors, Symptoms, and Mortality Drivers\u003c\/p\u003e\n\u003cp\u003eFDG PET in Sarcoidosis- Practical Considerations\u003c\/p\u003e\n\u003cp\u003eFlurpiridaz- The Ideal PET Perfusion Tracer\u003c\/p\u003e\n\u003cp\u003eGame-Show Jeopardy- Cardiac CT, Nuclear, and CMR\u003c\/p\u003e\n\u003cp\u003eHow to Integrate Stress Myocardial Blood Flow and Flow Reserve in Clinical Reporting and Guiding Therapy\u003c\/p\u003e\n\u003cp\u003eHow to Start Using Flurpiridaz- Lab Preparation, Protocols, Exercise vs Pharmacologic Stress\u003c\/p\u003e\n\u003cp\u003eIscheia Evaluation with Coronary CTA- FFRct\u003c\/p\u003e\n\u003cp\u003eMBF-MFR with Cardiac MRI- Becoming Routine in Stress MRI\u003c\/p\u003e\n\u003cp\u003eMBF-MFR with PET- How to Perform Quality Control, Interpret and Report\u003c\/p\u003e\n\u003cp\u003eMFR with SPECT- Ready for Prime Time-\u003c\/p\u003e\n\u003cp\u003eMRI in Cardiac Amyloidosis- Strengths and Limitations\u003c\/p\u003e\n\u003cp\u003eMy Best Teaching Cases\u003c\/p\u003e\n\u003cp\u003eMyocardial Bridging and Coronary Anomalies on Coronary CTA- When is Further Assessement Needed and What Should It Be\u003c\/p\u003e\n\u003cp\u003eMyocardial Viability- CMR and FDG PET\u003c\/p\u003e\n\u003cp\u003eNuclear Cardiology in 2026 and Beyond\u003c\/p\u003e\n\u003cp\u003ePerfusion and Blood Flow Quantitation- Transmural and Subendocardial\u003c\/p\u003e\n\u003cp\u003ePET or SPECT- Right Test for the Right Patient\u003c\/p\u003e\n\u003cp\u003ePharmacologic Stress- Combined with Exercise or Alone- What You Need to Know\u003c\/p\u003e\n\u003cp\u003ePlaque Imaging in Guiding Patient Management\u003c\/p\u003e\n\u003cp\u003eProblems fo Coronary CTA- Small Stents, CAC, Breathing\u003c\/p\u003e\n\u003cp\u003ePutting it All Together- Value-Based Use of Cardiac Imaging\u003c\/p\u003e\n\u003cp\u003eQuantitation in Sarcoidosis Interpretation\u003c\/p\u003e\n\u003cp\u003eQuantitative Plaque Analysis in Tracking Progression of Disease\u003c\/p\u003e\n\u003cp\u003eTc-99m Pyrophosphate (PYP) Imaging- Acquisition, Processing, Interpretation PET-based Radiotracers\u003c\/p\u003e\n\u003cp\u003eThe Disease, the Suspicion-Diagnostic Pathways, and Treatments\u003c\/p\u003e\n\u003cp\u003eThe Future of Cardiac CT- Photon Counting CT and More\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405745311940,"sku":null,"price":78.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Cedars-Sinai-Advances-in-Nuclear-Cardiology-Cardiac-CT-and-Cardiac-MRI-38th-Annual-Case-Review-with-the-Experts-2026.jpg?v=1784215543","url":"https:\/\/medicalcoursespro.com\/products\/cedars-sinai-advances-in-nuclear-cardiology-cardiac-ct-and-cardiac-mri-38th-annual-case-review-with-the-experts-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}